OngoingEUCTR 2005-001217-17
This study is comparing venlafaxine hydrochloride with placebo for people with Treatment resistant depression or Elderly. Participants receive venlafaxine hydrochloride or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- Max-Planck-Institute of Psychiatry
- Condition
- Depression
OngoingEUCTR 2009-011911-19
This study is comparing Seroquel Prolong 300 mg with Cipralex 10 mg for people with In this study, suffering from unipolar depression are investigated. 40 unipolar depressed inpatients enter the study after the procedure has been fully explained and written in.
DepressionOther
- Countries
- Germany
- Sponsor
- Ludwig-Maximilian-University of Munich, Department of Psychiatry
- Condition
- Depression
OngoingEUCTR 2016-001637-27
This study is comparing Quetiapine fumarate with Lithium carbonate for people with Treatment resistant depression. Treatment resistant depression, defined as failure to respond to two or more adequate doses of antidepressant in the cur or Elderly.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- South London and Maudsley NHS Foundation Trust [...] 1. South London and Maudsley NHS Foundation Trust 2. King's College London
- Condition
- Depression
OngoingEUCTR 2008-001913-51
This study is comparing Oxytocin with placebo for people with Postpartum depression. Participants receive Oxytocin or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Italy
- Sponsor
- ISTITUTO PER L'INFANZIA BURLO GAROFOLO
- Condition
- Depression
OngoingEUCTR 2013-004276-35
This study is comparing ASCORBIC ACID with colloidal Silica for people with The trial aims to treat depression. 4% when depressive disorders in general is studied.
DepressionOther
- Countries
- Spain
- Sponsor
- Hospital Regional Universitario. IBIMA
- Condition
- Depression
OngoingEUCTR 2010-022673-33
This study is looking at whether CRH Ferring can help people with In total 40 subjects, aged 20-65 years, with depressive symptoms, considered by their physician to need antidepressant treatment, will be recruited from primary care clinics in the Stockholm area. Participants receive the study medicine CRH Ferring and complete study visits and assessments.
DepressionOther
- Countries
- Sweden
- Sponsor
- Psykiatri Nordväst, Karolinska Universitetssjukhuset Solna
- Condition
- Depression
OngoingEUCTR 2008-005695-27
This study is looking at whether Cymbalta can help people with depression, moderately severe as principal DSM-IV diagnosis. Participants receive the study medicine Cymbalta and complete study visits and assessments.
DepressionOther
- Countries
- Netherlands
- Sponsor
- Eli Lilly Nederland
- Condition
- Depression
OngoingEUCTR 2010-024364-18
This study is looking at care and outcomes for people with emotional information processing. (Disease of interest is depression, however this trial is in or we will use a test battery that has previously been shown sensitive to the admin.
DepressionOther
- Countries
- Netherlands
- Sponsor
- Leiden University [...] 1. Leiden University 2. Leiden University Medical Center
- Condition
- Depression
OngoingEUCTR 2008-000041-60
This study is looking at whether Quetiapin can help people with The planned open and monocentric trial investigates quetiapine as a monotherapy for with unipolar depression and psychotic features. The aim of this pilot study is to investigate the antid.
DepressionOther
- Countries
- Germany
- Sponsor
- LWL Universitätsklinik für Psychiatrie Bochum
- Condition
- Depression
OngoingEUCTR 2013-001818-14
This study is comparing Escitalopram 5mg (RVG 30494) Nortriptyline 10mg (RVG 03285) and 25mg (RVG 03286) with placebo for people with depression. Participants receive Escitalopram 5mg (RVG 30494) Nortriptyline 10mg (RVG 03285) and 25mg (RVG 03286) or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Netherlands
- Sponsor
- University Medical Center Groningen
- Condition
- Depression
OngoingEUCTR 2020-001424-34
This study is comparing Zuranolone with placebo for people with Postpartum depression. Participants receive Zuranolone or placebo and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom, View results
- Sponsor
- Sage Therapeutics, Inc.
- Condition
- Depression
OngoingEUCTR 2022-000603-12
This study is comparing Syntocinon Nasal Spray with placebo for people with We examine the effects of oxytocin on mother-infant interaction among mothers with a postpartum depression. Participants receive Syntocinon Nasal Spray or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Netherlands
- Sponsor
- Radboud University
- Condition
- Depression
OngoingEUCTR 2020-000469-18
This study is comparing IP2018 with placebo for people with Male with a diagnosis of mild to moderate depression and ED as determined from the Hamilton depression scale score of 7 to 23 and International Index of Erectile Function score of. Participants receive IP2018 or placebo and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- Initiator Pharma
- Condition
- Depression
OngoingEUCTR 2017-002097-38
This study is comparing ADEMETIONINE with placebo for Depressive episode in people with childhood trauma. Participants receive ADEMETIONINE or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Netherlands
- Sponsor
- University Medical Centre Utrecht
- Condition
- Depression
OngoingEUCTR 2019-001692-37
9 for people with Males and females between 18-64 years with a diagnosis of chronic depression. 9 and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- University Hospital Tuebingen
- Condition
- Depression
OngoingEUCTR 2006-005531-17
This study is comparing Xenon pro Anaesthesia with placebo for people with depression and recurrent mayor depression or Elderly. Participants receive Xenon pro Anaesthesia or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- Klinik für Anästhesiologie Universitätsklinikum Aachen
- Condition
- Depression
OngoingEUCTR 2018-002942-35
This study is comparing Escitalopram oxalate with placebo for people with Depression in Parkinson's disease or Elderly. Participants receive Escitalopram oxalate or placebo and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- University College London Comprehensive Clinical Trials Unit
- Condition
- Depression
OngoingEUCTR 2009-016463-10
This study is looking at whether MIRTAZAPINE can help people with Major Depression. Participants receive the study medicine MIRTAZAPINE and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- LWL University Hospital Bochum
- Condition
- Depression
OngoingEUCTR 2005-005266-37
This study is comparing Escitalopram with placebo for people with Acute territorial infarction in the territory of the middle cerebral artery or Elderly. Participants receive Escitalopram or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- Central Institute for Mental Health, Mannheim, Div. of Gerontopsychiatry
- Condition
- Depression
OngoingEUCTR 2019-001621-27
This study is looking at whether ESKETAMINE can help people with depression. Participants receive the study medicine ESKETAMINE and complete study visits and assessments.
DepressionOther
- Countries
- Netherlands
- Sponsor
- University Medical Center Groningen
- Condition
- Depression
OngoingEUCTR 2014-001541-24
2). Participants receive CYCLOSERINE or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- University Medical Center Freiburg
- Condition
- Depression
OngoingEUCTR 2019-001023-13
This study is comparing Pramipexole dihydrochloride monohydrate with placebo for people with Treatment resistant depression or Elderly. Participants receive Pramipexole dihydrochloride monohydrate or placebo and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- University of Oxford / Clinical Trials and Research Governance
- Condition
- Depression
OngoingEUCTR 2018-003573-97
This study is comparing Psilocybin with placebo for people with depression or Elderly. Participants receive Psilocybin or placebo and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- King's College London [...] 1. King's College London 2. South London & Maudsley NHS Foundation Trust
- Condition
- Depression
OngoingEUCTR 2008-000453-35
This study is comparing Epoetin alfa with placebo for people with Early, mild dementia of the Alzheimer’s Type and therapy-refractory Major Depression or Elderly. Participants receive Epoetin alfa or placebo and complete study visits and assessments.
DepressionOther
- Countries
- Germany
- Sponsor
- Max-Planck-Institute of Experimental Medicine
- Condition
- Depression
OngoingEUCTR 2019-001683-29
This study is comparing N/A with placebo for people with Adjunctive Treatment in with depression with Anxious Distress with Suboptimal Response to Standard Antidepressants. Participants receive N/A or placebo and complete study visits and assessments.
DepressionOther
- Countries
- United Kingdom
- Sponsor
- Janssen-Cilag International NV
- Condition
- Depression